Calamos Advisors LLC Dexcom Inc Transaction History

Calamos Advisors LLC

$16.1 Billion
Q3 2024

A detailed history of Calamos Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Calamos Advisors LLC holds 175,096 shares of DXCM stock, worth $13.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

175,096

Previous 325,925 46.28%

Holding current value

$13.7 Million

Previous $37 Million 68.25%

% of portfolio

0.07%

Previous 0.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$64.0 - $116.06 $9.65 Million - $17.5 Million	-150,829 Reduced 46.28%	175,096 $11.7 Million
Q2 2024 Jul 25, 2024	BUY	$110.31 - $140.45 $4.64 Million - $5.91 Million	42,050 Added 14.81%	325,925 $37 Million
Q1 2024 May 08, 2024	BUY	$114.22 - $140.1 $1.03 Million - $1.26 Million	9,012 Added 3.28%	283,875 $39.4 Million
Q4 2023 Jan 31, 2024	SELL	$75.49 - $124.16 $1.2 Million - $1.98 Million	-15,932 Reduced 5.48%	274,863 $34.1 Million
Q3 2023 Oct 25, 2023	BUY	$86.06 - $137.93 $31,842 - $51,034	370 Added 0.13%	290,795 $27.1 Million
Q2 2023 Jul 28, 2023	BUY	$112.47 - $130.98 $4.02 Million - $4.68 Million	35,766 Added 14.04%	290,425 $37.3 Million
Q1 2023 May 03, 2023	SELL	$104.0 - $122.92 $1.48 Million - $1.75 Million	-14,207 Reduced 5.28%	254,659 $29.6 Million
Q4 2022 Jan 25, 2023	BUY	$84.98 - $122.67 $10.5 Million - $15.2 Million	123,607 Added 85.09%	268,866 $0
Q3 2022 Oct 24, 2022	BUY	$76.35 - $94.18 $2.24 Million - $2.76 Million	29,295 Added 25.26%	145,259 $11.7 Million
Q2 2022 Aug 01, 2022	BUY	$67.99 - $132.89 $4.43 Million - $8.67 Million	65,207 Added 128.47%	115,964 $8.64 Million
Q1 2022 May 03, 2022	BUY	$94.08 - $130.2 $641,155 - $887,312	6,815 Added 15.51%	50,757 $26 Million
Q4 2021 Feb 01, 2022	SELL	$129.87 - $162.82 $132,986 - $166,727	-1,024 Reduced 2.28%	43,942 $23.6 Million
Q3 2021 Oct 26, 2021	SELL	$106.71 - $143.18 $376,046 - $504,566	-3,524 Reduced 7.27%	44,966 $24.6 Million
Q2 2021 Jul 22, 2021	SELL	$80.99 - $107.93 $11,014 - $14,678	-136 Reduced 0.28%	48,490 $20.7 Million
Q1 2021 Apr 12, 2021	BUY	$84.79 - $104.74 $899,791 - $1.11 Million	10,612 Added 27.92%	48,626 $17.5 Million
Q4 2020 Jan 27, 2021	SELL	$78.0 - $104.5 $936 - $1,254	-12 Reduced 0.03%	38,014 $14.1 Million
Q3 2020 Oct 26, 2020	BUY	$95.51 - $112.95 $3.39 Million - $4.01 Million	35,469 Added 1387.13%	38,026 $15.7 Million
Q2 2020 Jul 27, 2020	BUY	$62.68 - $105.34 $100,538 - $168,965	1,604 Added 168.31%	2,557 $1.04 Million
Q1 2020 Apr 28, 2020	SELL	$47.79 - $75.63 $1,051 - $1,663	-22 Reduced 2.26%	953 $257,000
Q4 2019 Jan 15, 2020	SELL	$36.62 - $57.29 $20,214 - $31,624	-552 Reduced 36.15%	975 $213,000
Q3 2019 Oct 21, 2019	BUY	$35.53 - $43.8 $54,254 - $66,882	1,527 New	1,527 $228,000
Q2 2019 Aug 07, 2019	SELL	$27.84 - $38.92 $57,350 - $80,175	-2,060 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$28.07 - $38.18 $1,684 - $2,290	60 Added 3.0%	2,060 $245,000
Q4 2018 Jan 24, 2019	BUY	$26.99 - $37.37 $53,980 - $74,740	2,000 New	2,000 $240,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Dexcom Inc Transaction History